William Jarnagin has been named Chief of the newly formed Hepatopancreatobiliary (HPB) Service in the Department of Surgery. A successor to the Hepatobiliary Service, of which Dr. Jarnagin has served as Acting Chief for the past year, the new HPB Service will foster clinical and translational research in liver, biliary, and pancreas disease and will allow for centralization of research activities and clinical care. Dr. Jarnagin is a board-certified surgeon whose clinical expertise is the diagnosis and treatment of benign and malignant diseases of the liver, bile ducts, gallbladder, and pancreas. In his clinical research, he focuses on the pathogenesis of biliary tract cancer and is investigating novel treatment approaches for patients with primary liver cancer. He and his colleagues have also recently embarked on a trial to investigate a new image-guided surgical system that may help facilitate hepatic resections.

Dr. Jarnagin received his MD degree in 1984 from Rush Medical College. He did his residency training at the University of California, San Francisco, went on to complete fellowships there and at Memorial Sloan-Kettering, and joined the Memorial Sloan-Kettering staff in 1997. He will continue to serve as Vice Chair for Surgical Services in the Department of Surgery.